Cologne Cohort of Neutropenic Patients (CoCoNut)

University Hospital of Cologne100,000 enrolled

Overview

The Cologne Cohort of Neutropenic Patients (CoCoNut) is a non-interventional cohort study assessing risk factors, interventions, and outcome of immunosuppressed patients with or without opportunistic infections.

This prospective cohort was established with the aim of a comprehensive data collection of all patients developing neutropenia after receiving chemotherapy for any kind of malignant disease, treated in the University Hospital of Cologne.

Study Type

OBSERVATIONAL

Enrollment

100,000

Conditions

Hematological Malignancies Cancer Chemotherapy Neutropenia Immunosuppression

Interventions

AntiinfectivesDRUG

To analyze to efficacy of (novel) drug therapies

Eligibility

Sex: ALLMin age: 1 YearHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * immunosuppressed patients Exclusion Criteria: * none

Locations (1)

University Hospital of Cologne

Cologne, North Rhine-Westphalia, Germany

RECRUITING

Outcomes

Primary Outcomes

Long-term survival of hematology and oncology patients following neutropenia

Time frame: 2 years following last follow-up

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.